Promising hantavirus tools are moving forward after a recent cruise ship outbreak highlighted that no approved treatments or vaccines were available to protect people.
Limited funding remains the main obstacle, with researchers now seeking support to keep development going rather than let early progress stall.
The push reflects a broader gap in preparedness for hantavirus, where outbreaks can expose the lack of ready medical defenses.